{"disease":{"id":"thoracic-cancers","name":"thoracic cancers"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00242723","title":"Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining","phase":"","overall_status":"RECRUITING","enrollment_count":1310,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05406167","title":"Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"RefleXion Medical","has_results":false},{"nct_id":"NCT02045368","title":"Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"IGF Oncology, LLC","has_results":false},{"nct_id":"NCT02054104","title":"Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":21,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}